Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro

Journal of Molecular and Cellular Cardiology

Volumn 101, Issue , 2016, Pages 69-80

  Humeres, Claudio ^a   Vivar, Raúl ^a   Boza, Pia ^a   Muñoz, Claudia ^a   Bolivar, Samir ^a   Anfossi, Renatto ^a   Osorio, Jose Miguel ^a   Olivares Silva, Francisco ^a   García, Lorena ^a   Díaz Araya, Guillermo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Cardiac fibroblast; Macrophage polarization; TGF 1; TLR 4

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROSIS; FLOW CYTOMETRY; HEART FIBROBLAST; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 84995890910     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.10.014     Document Type: Article

References (58)

1. [1] Nah, D.Y., Rhee, M.Y., The inflammatory response and cardiac repair after myocardial infarction. Korean Circ J. 39:10 (2009), 393–398.
2. [2] Frangogiannis, N.G., Chemokines in ischemia and reperfusion. Thromb. Haemost. 97:5 (2007), 738–747.
3. [3] Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124:4 (2006), 783–801.
4. [4] Lech, M., Anders, H.J., Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim. Biophys. Acta 1832:7 (2013), 989–997.
5. [5] Díaz-Araya, G., Vivar, R., Humeres, C., Boza, P., Bolivar, S., Muñoz, C., Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions. Pharmacol. Res. 101 (2015), 30–40.
6. [6] Brown, R.D., Ambler, S.K., Mitchell, M.D., Long, C.S., The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 45 (2005), 657–687.
7. [7] Tomita, K., Takashina, M., Mizuno, N., Sakata, K., Hattori, K., Imura, J., et al. Cardiac fibroblasts: contributory role in septic cardiac dysfunction. J. Surg. Res. 193:2 (2015), 874–887.
8. [8] Zhang, W., Xu, X., Kao, R., Mele, T., Kvietys, P., Martin, C.M., et al. Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS One, 9(9), 2014, e107639.
9. [9] Baudino, T.A., Carver, W., Giles, W., Borg, T.K., Cardiac fibroblasts: friend or foe?. Am. J. Physiol. Heart Circ. Physiol. 291:3 (2006), H1015–H1026.
10. [10] Atamas, S.P., Complex cytokine regulation of tissue fibrosis. Life Sci. 72:6 (2002), 631–643.
11. [11] Boza, P., Ayala, P., Vivar, R., Humeres, C., Cáceres, F.T., Muñoz, C., et al. Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation. Mol. Immunol. 74 (2016), 96–105.
12. [12] Scriba, A., Luciano, L., Steiniger, B., High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J. Immunol. Methods 189:2 (1996), 203–216.
13. [13] Haas, P., Straub, R.H., Bedoui, S., Nave, H., Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats. Regul. Pept. 151:1–3 (2008), 26–34.
14. [14] Grau, V., Scriba, A., Stehling, O., Steiniger, B., Monocytes in the rat. Immunobiology 202:1 (2000), 94–103.
15. [15] Badylak, S.F., Valentin, J.E., Ravindra, A.K., McCabe, G.P., Stewart-Akers, A.M., Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 14:11 (2008), 1835–1842.
16. [16] Buckley, C.D., Pilling, D., Lord, J.M., Akbar, A.N., Scheel-Toellner, D., Salmon, M., Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:4 (2001), 199–204.
17. [17] Yusuf-Makagiansar, H., Anderson, M.E., Yakovleva, T.V., Murray, J.S., Siahaan, T.J., Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med. Res. Rev. 22:2 (2002), 146–167.
18. [18] Kacimi, R., Karliner, J.S., Koudssi, F., Long, C.S., Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ. Res. 82:5 (1998), 576–586.
19. [19] Turner, N.A., Das, A., O'Regan, D.J., Ball, S.G., Porter, K.E., Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation. Int. J. Biochem. Cell Biol. 43:10 (2011), 1450–1458.
20. [20] Fukuda, K., Kumagai, N., Yamamoto, K., Fujitsu, Y., Chikamoto, N., Nishida, T., Potentiation of lipopolysaccharide-induced chemokine and adhesion molecule expression in corneal fibroblasts by soluble CD14 or LPS-binding protein. Invest. Ophthalmol. Vis. Sci. 46:9 (2005), 3095–3101.
21. [21] Chakravortty, D., Kumar, K.S., Interaction of lipopolysaccharide with human small intestinal lamina propria fibroblasts favors neutrophil migration and peripheral blood mononuclear cell adhesion by the production of proinflammatory mediators and adhesion molecules. Biochim. Biophys. Acta 1453:2 (1999), 261–272.
22. [22] Canbay, A., Feldstein, A., Baskin-Bey, E., Bronk, S.F., Gores, G.J., The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J. Pharmacol. Exp. Ther. 308:3 (2004), 1191–1196.
23. [23] Viñas, O., Bataller, R., Sancho-Bru, P., Ginès, P., Berenguer, C., Enrich, C., et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38:4 (2003), 919–929.
24. [24] Chen, Y., Kam, C.S., Liu, F.Q., Liu, Y., Lui, V.C., Lamb, J.R., et al. LPS-induced up-regulation of TGF-beta receptor 1 is associated with TNF-alpha expression in human monocyte-derived macrophages. J. Leukoc. Biol. 83:5 (2008), 1165–1173.
25. [25] Hosokawa, Y., Hosokawa, I., Ozaki, K., Nakae, H., Matsuo, T., Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts. Clin. Exp. Immunol. 144:3 (2006), 494–502.
26. [26] Frangogiannis, N.G., Smith, C.W., Entman, M.L., The inflammatory response in myocardial infarction. Cardiovasc. Res. 53:1 (2002), 31–47.
27. [27] Lindner, D., Zietsch, C., Tank, J., Sossalla, S., Fluschnik, N., Hinrichs, S., et al. Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Res. Cardiol., 109(5), 2014, 428.
28. [28] Morimoto, H., Takahashi, M., Izawa, A., Ise, H., Hongo, M., Kolattukudy, P.E., et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ. Res. 99:8 (2006), 891–899.
29. [29] Frangogiannis, N.G., The immune system and cardiac repair. Pharmacol. Res. 58:2 (2008), 88–111.
30. [30] Hohensinner, P.J., Kaun, C., Rychli, K., Ben-Tal Cohen, E., Kastl, S.P., Demyanets, S., et al. Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia. FEBS Lett. 580:14 (2006), 3532–3538.
31. [31] Gharaee-Kermani, M., Denholm, E.M., Phan, S.H., Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 271:30 (1996), 17779–17784.
32. [32] Frangogiannis, N.G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115:5 (2007), 584–592.
33. [33] Chomarat, P., Banchereau, J., Davoust, J., Palucka, A.K., IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:6 (2000), 510–514.
34. [34] Wang, N., Liang, H., Zen, K., Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol., 5, 2014, 614.
35. [35] Siwik, D.A., Chang, D.L., Colucci, W.S., Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 86:12 (2000), 1259–1265.
36. [36] Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:3 (2012), 787–795.
37. [37] Yamane, K., Ihn, H., Asano, Y., Jinnin, M., Tamaki, K., Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. J. Immunol. 171:7 (2003), 3855–3862.
38. [38] Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A.A., Rojkind, M., et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14:2 (2000), 187–197.
39. [39] Inagaki, Y., Truter, S., Tanaka, S., Di Liberto, M., Ramirez, F., Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription. J. Biol. Chem. 270:7 (1995), 3353–3358.
40. [40] Yang, Z., Zingarelli, B., Szabó, C., Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101:9 (2000), 1019–1026.
41. [41] LaFramboise, W.A., Scalise, D., Stoodley, P., Graner, S.R., Guthrie, R.D., Magovern, J.A., et al. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am. J. Phys. Cell Phys. 292:5 (2007), C1799–C1808.
42. [42] Rossini, A., Zacheo, A., Mocini, D., Totta, P., Facchiano, A., Castoldi, R., et al. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J. Mol. Cell. Cardiol. 44:4 (2008), 683–693.
43. [43] de Waal, M.R., Abrams, J., Bennett, B., Figdor, C.G., de Vries, J.E., Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:5 (1991), 1209–1220.
44. [44] Darrieutort-Laffite, C., Boutet, M.A., Chatelais, M., Brion, R., Blanchard, F., Heymann, D., et al. IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts. Mediat. Inflamm., 2014, 2014, 241840.
45. [45] Fredj, S., Bescond, J., Louault, C., Delwail, A., Lecron, J.C., Potreau, D., Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J. Cell. Physiol. 204:2 (2005), 428–436.
46. [46] Ma, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., et al. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One, 7(5), 2012, e35144.
47. [47] Hashem, R.M., Mahmoud, M.F., El-Moselhy, M.A., Soliman, H.M., Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. Eur J Gastroenterol Hepatol. 20:10 (2008), 995–1001.
48. [48] Kaur, K., Sharma, A.K., Singal, P.K., Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 291:1 (2006), H106–H113.
49. [49] Landmesser, U., Wollert, K.C., Drexler, H., Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc. Res. 81:3 (2009), 519–527.
50. [50] Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 17:5 (2011), 581–588.
51. [51] Swirski, F.K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:5940 (2009), 612–616.
52. [52] Matthijs, B.W., Has the search for a marker of activated fibroblasts finally come to an end?. J. Mol. Cell. Cardiol. 88 (2015), 120–123.
53. [53] Nahrendorf, M., Swirski, F.K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.L., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:12 (2007), 3037–3047.
54. [54] Pinto, A.R., Godwin, J.W., Rosenthal, N.A., Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation. Stem Cell Res. 13 (2014), 705–714 (3 Pt B).
55. [55] Pinto, A.R., Paolicelli, R., Salimova, E., Gospocic, J., Slonimsky, E., Bilbao-Cortes, D., et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One, 7(5), 2012, e36814.
56. [56] Martinez, F.O., Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep., 6, 2014, 13.
57. [57] Heppner, F.L., Ransohoff, R.M., Becher, B., Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16:6 (2015), 358–372.
58. [58] Nahrendorf, M., Swirski, F.K., Monocyte and macrophage heterogeneity in the heart. Circ. Res. 112:12 (2013), 1624–1633.